Clinical trial Recruiting at 1 site Observational Ages 18 and up

Using liquid biopsies to detect mutations in brain arteriovenous malformations

Official title: Liquid Biopsies for the Detection of Somatic Mutations in Brain Arteriovenous Malformations

Run by Assistance Publique - Hôpitaux de Paris · NCT06494358 · Data updated 2026-11-12

This study is testing if a simple blood test can help find genetic changes in people with brain arteriovenous malformations to better understand their condition and improve treatment options.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedApril 1, 2025
Main results expectedDecember 1, 2027
Study endsDecember 1, 2027
Registry record updatedAugust 31, 2026
Trial IDNCT06494358 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who are being treated for bAVMs at Pitié-Salpêtrière Hospital and are indicated for embolization followed by surgery.

Probably not a fit

Patients with extra-cerebral arteriovenous malformations, those under legal protection, pregnant individuals, or those not eligible for combined treatment will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on the use of liquid biopsies to identify somatic mutations in patients with brain arteriovenous malformations (bAVMs). It aims to explore the genetic underpinnings of bAVMs, which have traditionally been considered non-genetic, by analyzing circulating DNA. The study will involve patients treated at Pitié-Salpêtrière Hospital who are undergoing embolization followed by surgery. By utilizing next-generation sequencing, the research seeks to provide a non-invasive method for studying these mutations and potentially guiding treatment strategies.

Why it matters

Potential benefit: If successful, this approach could lead to more personalized treatment options for patients with bAVMs, improving outcomes and reducing risks associated with these malformations.

How similar studies have gone: While the use of liquid biopsies is a relatively novel approach in this context, there is emerging evidence supporting its effectiveness in other vascular conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
"\_Age ≥ 18 years

* Treated for bAVM at Pitié-Salpêtrière Hospital
* Indication for treatment by embolization followed by surgery decided in a multidisciplinary consultation meeting (RCP) at Pitié-Salpêtrière Hospital
* Treatment by embolization possibly followed by surgery within 24-48 hours if the embolization is incomplete
* Informed about the study and not objecting to participation"

Exclusion criteria :

* Extra-cerebral arteriovenous malformations
* Under legal protection (guardianship/curators, etc.)
* Pregnancy
* Not eligible for combined treatment (embolization followed by surgery)

Where it's running

  • Unité de neuroradiologie interventionnelle, hôpital Pitié-Salpêtrière
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.